UB Paderborn / Katalog / Suche / in CDI

Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME

World journal of gastroenterology : WJG, 2017-08, Vol.23 (29), p.5304-5312

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats

PloS one, 2016-09, Vol.11 (9), p.e0162590

2016

Link zum Volltext

Verfügbarkeit prüfen

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine

PloS one, 2015-04, Vol.10 (4), p.e0123454-e0123454

2015

Link zum Volltext

Verfügbarkeit prüfen

Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME

World journal of gastroenterology : WJG, 2016-11, Vol.22 (41), p.9127-9140

2016

Link zum Volltext

Verfügbarkeit prüfen

Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats

Biomedicines, 2021-09, Vol.9 (9), p.1206

2021

Link zum Volltext

Verfügbarkeit prüfen

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation

European journal of pharmacology, 2019-03, Vol.847, p.130-142

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME

European journal of pharmacology, 2019-10, Vol.861, p.172593-172593, Article 172593

2019

Link zum Volltext

Verfügbarkeit prüfen

587 – Pentadecapeptide Bpc 157 Therapy in Bile Duct Ligated (BDL) Rats. in the Liver Tissue, Bpc 157 Counteracts the Increased Nos3 Expression, Il-6, TNF-Α, Il-1Β Levels, and Ki-67 Presentation

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-113-S-114

2019

Link zum Volltext

Verfügbarkeit prüfen

Su1486 - Bpc 157 Therapy of Portal Hypertension in Bile Duct Ligated Rats

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-536-S-536

2018

Link zum Volltext

Verfügbarkeit prüfen

Su1078 PENTADECAPEPTIDE BPC 157 THERAPY IN BILE DUCT LIGATED (BDL) RATS. IN RATS WITH CIRRHOSIS AND PORTAL HYPERTENSION, BPC 157 MAY BE USEFUL ALSO IN THE CONDITIONS OF THE INCREASED INTRACRANIAL PRESSURE AND VESSELS OBSTRUCTION

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-502-S-502

2020

Link zum Volltext

Verfügbarkeit prüfen

Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157

Vascular pharmacology, 2018-07, Vol.106, p.54-66

2018

Link zum Volltext

Verfügbarkeit prüfen

Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula

European journal of pharmacology, 2016-06, Vol.780, p.1-7

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of cyclin A2 and B1 expression in lung carcinoids

Pathology, 2019-08, Vol.51 (5), p.481-486

2019

Link zum Volltext

Verfügbarkeit prüfen

Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats

Life sciences (1973), 2016-03, Vol.148, p.63-70

2016

Link zum Volltext

Verfügbarkeit prüfen

Stable Pentadecapeptide BPC 157 and Vesicovaginal Fistulas in Rats

The FASEB journal, 2018-04, Vol.32 (S1), p.832.15-832.15

2018

Link zum Volltext

Verfügbarkeit prüfen

Sa1612 70% Liver Resection in Rats. Pentadecapeptide BPC 157, L-Arginine, L-NAME: BPC 157 Beneficial Effect Counteracts Worsening Induced by L-NAME

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S342-S343

2016

Link zum Volltext

Verfügbarkeit prüfen

Tu1417 Rat Rectovaginal Fistulas Are Augmented After Either L-NAME Administration or L-Arginine Administration. Counteraction by Stable Gastric Pentadecapeptide BPC 157

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S899-S899

2016

Link zum Volltext

Verfügbarkeit prüfen

Mo1260 Cysteamine Duodenal Ulcerogenic Potential Is Augmented With Stomach Lesions After Either L-NAME Administration or L-Arginine Administration. Counteraction by Stable Gastric Pentadecapeptide BPC 157

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S681-S681

2016

Link zum Volltext

Verfügbarkeit prüfen

BPC 157 Counteracts Gastric Lesions after Bilateral Nephrectomy and Attenuates Deleterious Course in Rats

The FASEB journal, 2015-04, Vol.29 (S1)

2015

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of the Deleterious Course and Gastric Lesions after Bilateral Nephrectomy in Rats, NO‐system relation. BPC 157, L‐arginine, L‐NAME

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Tu1959 Effect of Pentadecapeptide BPC 157 on Liver Lesions Induced by Biliary Obstruction in Rats

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-882-S-882

2014

Link zum Volltext

Verfügbarkeit prüfen

Tu2028 Pentadecapeptide BPC 157 After 70% Liver Resection in Rats

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-964-S-964

2015

Link zum Volltext

Verfügbarkeit prüfen

Mo1262 Acetic Acid Early Destructive Potential for Gastric Blood Vessels and Consequent Ulcerogenic Capability in Rats Were Augmented by NOS-Blockade (L-NAME) and Counteracted by NOS-Substrate Administration (L-Arginine), and BPC 157 Administration

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S682-S682

2016

Link zum Volltext

Verfügbarkeit prüfen

Sa1977 - Counteraction of Ischemic Colitis Lesion in Rats: Pentadecapeptide BPC 157, L-Name, L-Arginine

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S414-S414

2017

Link zum Volltext

Verfügbarkeit prüfen

Counteraction of Ischemic Colitis Lesion in Rats: Pentadecapeptide BPC 157, L-Name, L-Arginine

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S414-S414

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME

Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine

Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME

Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation

Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME

587 – Pentadecapeptide Bpc 157 Therapy in Bile Duct Ligated (BDL) Rats. in the Liver Tissue, Bpc 157 Counteracts the Increased Nos3 Expression, Il-6, TNF-Α, Il-1Β Levels, and Ki-67 Presentation

Su1486 - Bpc 157 Therapy of Portal Hypertension in Bile Duct Ligated Rats

Su1078 PENTADECAPEPTIDE BPC 157 THERAPY IN BILE DUCT LIGATED (BDL) RATS. IN RATS WITH CIRRHOSIS AND PORTAL HYPERTENSION, BPC 157 MAY BE USEFUL ALSO IN THE CONDITIONS OF THE INCREASED INTRACRANIAL PRESSURE AND VESSELS OBSTRUCTION

Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157

Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula

Prognostic value of cyclin A2 and B1 expression in lung carcinoids

Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats

Stable Pentadecapeptide BPC 157 and Vesicovaginal Fistulas in Rats

Sa1612 70% Liver Resection in Rats. Pentadecapeptide BPC 157, L-Arginine, L-NAME: BPC 157 Beneficial Effect Counteracts Worsening Induced by L-NAME

Tu1417 Rat Rectovaginal Fistulas Are Augmented After Either L-NAME Administration or L-Arginine Administration. Counteraction by Stable Gastric Pentadecapeptide BPC 157

Mo1260 Cysteamine Duodenal Ulcerogenic Potential Is Augmented With Stomach Lesions After Either L-NAME Administration or L-Arginine Administration. Counteraction by Stable Gastric Pentadecapeptide BPC 157

BPC 157 Counteracts Gastric Lesions after Bilateral Nephrectomy and Attenuates Deleterious Course in Rats

Attenuation of the Deleterious Course and Gastric Lesions after Bilateral Nephrectomy in Rats, NO‐system relation. BPC 157, L‐arginine, L‐NAME

Tu1959 Effect of Pentadecapeptide BPC 157 on Liver Lesions Induced by Biliary Obstruction in Rats

Tu2028 Pentadecapeptide BPC 157 After 70% Liver Resection in Rats

Mo1262 Acetic Acid Early Destructive Potential for Gastric Blood Vessels and Consequent Ulcerogenic Capability in Rats Were Augmented by NOS-Blockade (L-NAME) and Counteracted by NOS-Substrate Administration (L-Arginine), and BPC 157 Administration

Sa1977 - Counteraction of Ischemic Colitis Lesion in Rats: Pentadecapeptide BPC 157, L-Name, L-Arginine

Counteraction of Ischemic Colitis Lesion in Rats: Pentadecapeptide BPC 157, L-Name, L-Arginine

Suchergebnisse filtern